|Medical School & PhD in Immunology: Oregon Health & Science University Master’s Degree in Biochemistry: Universite Claude Bernard Lyon, France
|University of California, Irvine
|Uveitis & Ocular Inflammation, Massachusetts Eye Research and Surgery Institution, Harvard Medical School, Vitreoretinal Surgery and Diseases, University of California, San Diego
|Uveitis and Ocular Inflammation
Doran B. Spencer, M.D., Ph.D., is an Assistant Professor of Ophthalmology at the Shiley Eye Institute, U.C.S.D. He is a specialist in uveitis and ocular inflammation as well as diseases and surgery of the retina. Dr. Spencer earned a Bachelor’s of Science at the University of Oregon, where he was a student in the Honor’s College. He also obtained a Master’s Degree of Biochemistry at the Université Claude Bernard Lyon 1 in Lyon, France, where he worked at the Pasteur Institut. He completed his M.D. and a Ph.D. in Immunology at Oregon Health and Science University, where he studied animal models of uveitis. His Ophthalmology residency and Internal Medicine Preliminary training were at the University of California, Irvine. He then completed a year-long Uveitis fellowship with Dr. C. Stephen Foster at the Massachusetts Eye Research and Surgery Institution, where he was a Clinical Instructor in Ophthalmology at the Massachusetts Eye and Ear Infirmary, Harvard Medical School. He then completed his Vitreoretinal surgery fellowship at the University of California, San Diego, where he has been seeing uveitis patients since 2017. He has been honored with many awards, including the National Merit Scholarship and a research award from the American Society of Cataract and Refractive Surgery.
Dr. Spencer’s clinical focus is in the medical and surgical treatment of uveitis and ocular inflammation. Additionally, he treats diseases of the retina both medically and surgically. He is an experienced clinical researcher and participates in numerous clinical trials for uveitis and retinal diseases. This includes several studies of his own design focused on novel clinical findings and imaging modalities for uveitis and retinal diseases. Additionally, he partakes in multiple interdisciplinary collaborations aimed at understanding novel causes of uveitis such as cancer immunotherapy.
Dr. Spencer’s approach to uveitis prioritizes minimizing damage to the eye from ongoing inflammation. As a Uveitis specialist, Dr. Spencer is trained to manage ocular inflammation with systemic non-steroidal anti-inflammatory treatment, which often results in long-term remission without recurrence of inflammation. When appropriate, this includes a multidisciplinary approach involving collaboration with additional medical specialists at UCSD when the eye inflammation is associated with systemic disease.
The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.
The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.
The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.
Click Here To Accept